Post by Alexion Pharmaceuticals, Inc.

Alexion, AstraZeneca Rare Disease was proud to support MassBio’s annual State of Possible as a sponsor, bringing together leaders across the life sciences ecosystem to advance innovation and collaboration. The event also marked the conclusion of Alexion VP Tamar Thompson’s term as the Chair of the MassBio Board of Directors. We recognize her efforts to drive policy and patient advocacy, and for supporting job opportunities for underserved communities through the Bioversity program. We remain committed to working alongside partners across the community to support patients and their families, and to build on the momentum that will shape the future of rare disease innovation. #StateOfPossible #RareDisease #MassBio #Biotech